JWJanine Wirth

Janine Wirth

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Janine Wirth has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Cornelia Weikert

    Federal Institute of Risk Assessment, Department of Food Safety , Berlin, Germany

    3 shared publications
  • Edward Giovannucci

    3 shared publications
  • Amit D Joshi

    Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School , Boston, MA, USA Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School , Boston, MA, USA

    2 shared publications
  • Andrew T Chan

    Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School , Boston, MA, USA Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School , Boston, MA, USA Channing Division of Network Medicine, Department of Medicine, Harvard Medical School , Boston, MA, USA Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health , Boston, MA, USA

    2 shared publications
  • Fred K Tabung

    Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston , MA, USA Division of Medical Oncology, The Ohio State University Wexner Medical Center , Columbus, OH, USA The Ohio State University Comprehensive Cancer Center—James Cancer Hospital and Solove Research Institute , Columbus, OH, USA

    2 shared publications
  • Kana Wu

    Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston , MA, USA

    2 shared publications

Latest Publications

  • Protein intake and its effect on sleep outcomes: a systematic review and meta-analysis of randomized controlled trials

    by Janine Wirth, Elaine Hillesheim, Lorraine Brennan

    Poor sleep is increasingly seen as an issue of public health concern. In recent years, there has been growing interest in protein as a route to improve sleep outcomes; however, the evidence is limited and inconclusive. To examine, using a systematic review and meta-analysis, the effect of increased protein intake (≥1 g/kg//d, ≥25% of total energy intake, or protein supplementation of ≥10 g/d/) on sleep outcomes in adults. On November 30, 2021, 5 electronic databases were searched to identify relevant randomized controlled trials (PubMed, Cochrane, Embase, Web of Science, and CINAHL Plus). Risk of bias was assessed using the Cochrane Risk-of-Bias tool, version 2.0. Five sleep outcomes were included in this systematic review (sleep quality [SQ], sleep latency [SL], sleep efficiency [SEff], sleep time [ST], wake episodes, and other sleep outcomes) and 4 in the meta-analysis (SQ, SL, SEff, and ST). The quality of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation approach. Twelve intervention studies reported on in 10 articles were included. The qualitative analyses showed that increased protein consumption has little influence on sleep outcomes. Only subjective SQ was positively associated with protein consumption in a few studies. Meta-analyses also showed no significant effect of increased protein intake on sleep outcomes (number of studies for SQ, ST, SL, and SEff: 8, 8, 7, and 6, respectively), with very low certainty of evidence. However, results from sensitivity analyses, excluding high-risk studies, suggest a small effect on SQ in favor of high protein intake (mean difference, –4.28; 95%CI, –7.77, –0.79; on a scale from 0 to 100). This systematic review and meta-analysis indicate there is no clear relationship between increased protein intake and sleep. However, the strength of the evidence is low and more randomized controlled trials that focus on this specific research question are warranted. Systematic Review Registration: PROSPERO registration no. CRD42020196021.


  • Tu1243: MENOPAUSAL HORMONE THERAPY, OBESITY, AND RISK OF SYMPTOMATIC GALLSTONE DISEASE

    by Junghyun Lim, Manol Jovani, Janine Wirth, Kana Wu, Erica T. Warner, Edward Giovannucci, Andrew Chan, Amit D. Joshi

  • Open Access

    A healthy lifestyle pattern and the risk of symptomatic gallstone disease: results from 2 prospective cohort studies

    by Janine Wirth, Amit D Joshi, Mingyang Song, Dong Hoon Lee, Fred K Tabung, Teresa T Fung, Andrew T Chan, Cornelia Weikert, Michael Leitzmann, Walter C Willett, et al.

    Symptomatic gallstones cause high financial and disease burden for public health systems. The combined role of diet and other lifestyle factors has not been studied so far. We aimed to investigate the association between an a priori defined healthy lifestyle score (HLS, including healthy diet, moderate alcohol and regular coffee intakes, never smoking, physical activity, and normal weight) and the risk of symptomatic gallstone disease, and to estimate the proportion of cases potentially preventable by lifestyle modification. We followed 60,768 women from the Nurses’ Health Study (NHS) and 40,744 men from the Health Professionals Follow-up Study (HPFS), both ongoing prospective cohort studies, from baseline (1986) until 2012. Symptomatic gallstone disease was self-reported and validated by review of medical records. The association between the HLS and the risk of symptomatic gallstone disease was investigated using Cox proportional hazards regression. During 1,156,079 and 769,287 person-years of follow-up, respectively, 6946 women and 2513 men reported symptomatic gallstone disease. Comparing 6 with 0 points of the HLS, the multivariable HR of symptomatic gallstone disease was 0.26 (95% CI: 0.15, 0.45) for women, and 0.17 (95% CI: 0.07, 0.43) for men. For individual lifestyle factors, multivariable and mutually adjusted partial population attributable risks (women and men) were 33% and 23% for BMI 2, 10% and 18% for ≥2 cups of coffee per day, 13% and 7% for moderate alcohol intake, 8% and 11% for a high Alternate Healthy Eating Index 2010, 9% and 5% for being physically active, and 1% and 5% for never smoking. The full population attributable risk percentage for all factors combined was 62% and 74%, respectively. Findings from these large prospective studies indicate that adopting a healthy lifestyle, especially maintaining a healthy weight, can help to prevent a considerable proportion of symptomatic gallstone diseases.


  • Diet-quality scores and the risk of symptomatic gallstone disease: a prospective cohort study of male US health professionals

    by Janine Wirth, Mingyang Song, Teresa T Fung, Amit D Joshi, Fred K Tabung, Andrew T Chan, Cornelia Weikert, Michael Leitzmann, Walter C Willett, Edward Giovannucci, et al.

    Objective: To investigate the association between three diet-quality scores corresponding to adherence to healthy dietary patterns [alternate Mediterranean (aMed), Alternate Healthy Eating Index (AHEI-2010), Dietary Approaches to Stop Hypertension (DASH)] and the risk of symptomatic gallstone disease. Methods: The study comprised 43 635 men of the Health Professionals Follow-up Study-an ongoing prospective cohort study of US health professionals. Participants were free of symptomatic gallstone disease and diabetes and provided dietary information every 4 years from 1986 (baseline) until 2012. The aMed, AHEI-2010 and DASH scores were generated and associated with the risk of symptomatic gallstone disease using Cox proportional hazards regression. Results: During 716 904 person-years of follow-up, 2382 incident cases of symptomatic gallstone disease were identified. All three scores were inversely associated with risk of symptomatic gallstone disease after adjustment for potential confounders including age, smoking, physical activity, energy and coffee intake [hazard ratios (HRs) and 95% confidence intervals (CIs)] comparing the highest with the lowest quintiles: aMed: 0.66 (0.57-0.77), AHEI-2010: 0.64 (0.56-0.74) and DASH: 0.66 (0.58-0.76)]. Findings were similar after additional adjustment for body mass index and after inclusion of asymptomatic cases. Associations were stronger when analysis was restricted to cases who had undergone cholecystectomy. Conclusions: In this prospective cohort of male US health professionals, higher adherence to the aMed, AHEI-2010 and DASH diets was associated with lower risk of symptomatic gallstone disease. Dietary recommendations focusing on high-quality diets targeting symptomatic gallstone disease may lower the incidence of this prevalent disease.


  • Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study

    by Janine Wirth, Dorothee Atzler, Romina di Giuseppe, Kathrin Cordts, Juliane Menzel, Rainer H. Böger, Heiner Boeing, Cornelia Weikert, Edzard Schwedhelm

    L-Arginine is the substrate of endothelial nitric oxide (NO) synthase forming NO which inherits various biological cardio-protective functions. The dimethylarginines asymmetric (ADMA) and symmetric dimethylarginine (SDMA) can impair the synthesis of NO and are elevated in patients with cardiovascular disease, including heart failure (HF). We investigated the association between dimethylarginines and HF risk in a case-cohort study of the European Prospective Investigation into Cancer and Nutrition (n = 27,548), comprising a random subcohort (n = 2224 including 19 HF cases), and all remaining HF cases (n = 176) that occurred within 8.3 years of follow-up. Serum concentrations of dimethylarginines were measured using liquid chromatography-tandem mass spectrometry. Hazards ratios (HRs) and 95% confidence intervals (CI) were estimated across quartiles and per doubling of ADMA and SDMA concentrations using Cox’s proportional hazards regression. After multivariable adjustment, each doubling of ADMA was associated with a 60% higher HF risk (HR [95% CI] 1.60 [1.10–2.31]). Between SDMA and HF risk a U-shaped association was observed (HR [95% CI] for the second, third and fourth quartile compared to the first: 0.52 [0.33–0.82], 0.63 [0.40–0.99], and 0.71 [0.46–1.10], p for nonlinearity <0.01). We provide substantiated evidence for a relationship between ADMA and cardiovascular endpoints. In addition to the established relation between ADMA and myocardial infarction, our findings indicate a positive association between ADMA and HF incidence in persons without apparent myocardial infarction. Targeting the ADMA metabolism might open up new therapeutic perspective for HF prevention and treatment. Further investigations are needed to shed more light on mechanisms involved in the pathogenesis of HF related to elevated ADMA levels.